The Jill Roberts Center for Inflammatory Bowel Disease is dedicated to the research and treatment of inflammatory bowel disease (IBD), a condition affecting more than 1 million Americans that most often results from two specific diseases: ulcerative colitis and Crohn's disease.
Our mission is to improve patient care by personalizing therapies for IBD and to discover cures for Crohn’s disease and colitis.
The JRC is one of the nation’s leading multidisciplinary centers for the diagnosis, comprehensive care and innovative treatment of patients with IBD. We offer integrated clinical services from the NewYork-Presbyterian Hospital and Weill Cornell Medicine network, including access to world-class surgeons, pediatricians, rheumatologists and hepatologists.
We offer patients early, effective IBD interventions, including cutting edge clinical trials that aim to treat and prevent the progression of Crohn’s disease and colitis.
Building on the delivery of comprehensive care, we are committed to improving the lives of patients and families by developing unique clinical services, including a dedicated IBD nutrition program, stress management support, an IBD-related musculoskeletal health and wellness program that focuses on bone, muscle and joint health, IBD genetic testing and counseling and dysplasia/colorectal cancer screening and surveillance programs.
Our goal is to develop novel, safer treatments through “lab to life” research, translating laboratory discoveries into transformative therapies that improve patients’ lives.
To learn more about our services or to make an appointment, visit the center's website or call us at (212) 746-5077.